Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-217
Closed -$10.6K 511
2025
Q4
$10.6K Buy
+217
New +$10.1K ﹤0.01% 430
2023
Q2
Sell
-160
Closed -$5.69K 447
2023
Q1
$5.69K Hold
160
﹤0.01% 414
2022
Q4
$5.62K Sell
160
-248
-61% -$8.26K ﹤0.01% 416
2022
Q3
$12K Buy
+408
New +$15.5K ﹤0.01% 371
2021
Q1
Sell
-1,020
Closed -$47K 484
2020
Q4
$47K Hold
1,020
0.01% 306
2020
Q3
$48K Hold
1,020
0.01% 297
2020
Q2
$52K Buy
+1,020
New +$52.3K 0.01% 289
2017
Q1
Sell
-148
Closed -$7K 452
2016
Q4
$7K Sell
148
-69
-32% -$3.41K ﹤0.01% 383
2016
Q3
$12K Hold
217
﹤0.01% 346
2016
Q2
$12K Hold
217
﹤0.01% 347
2016
Q1
$11K Hold
217
﹤0.01% 349
2015
Q4
$11K Buy
+217
New +$11.1K ﹤0.01% 357

Other funds holding GSK

Community Bank's GSK Position: Q1 2026 in Review

Community Bank sold out of GSK (GSK) in Q1 2026, closing a stake of 217 shares — an estimated $10.6K sold.

Community Bank first reported a position in GSK in Q4 2015 and held it in 12 quarters. The position peaked at $52K in Q2 2020. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Community Bank reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Community Bank sold 217 GSK shares in Q1 2026, an estimated $10.6K.
  • Community Bank first reported a position in GSK in Q4 2015 and held it in 12 quarters.
  • Community Bank's GSK position peaked at $52K in Q2 2020.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Community Bank's 13F filing for Q1 2026, filed 12 May 2026.